Could see a trade halt re 1308 top line data announcement at any...

Could see a trade halt re 1308 top line data announcement at any moment from here.........

You'd think it's all done bar the shouting...........data being collated and so on right now..........plenty of info to 'rummage' through on this study.

I'm optimistic on the results as AD and psoriasis involve very similar pathways..........."Atopic dermatitis (and psoriasis) are both T-cell mediated inflammatory diseases of the skin"..........and the AD phase 1b data was impressive imo.

Re AD (BTX1204)..........."Efficacy still increasing at 4 week timepoint"........we also have a confirmed safety profile which allows for extended dosing as @NZ Trader points out.

Getting very very close to seeing something, (even though we've been told Q2 for the release)............Q2 ain't too far off anyway.

With two products through to phase 2, my thoughts are we'll probably have yet another in 1308.......but until the ann drops.........nothing is certain.